Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q12864
UPID:
CAD17_HUMAN
Alternative names:
Intestinal peptide-associated transporter HPT-1; Liver-intestine cadherin
Alternative UPACC:
Q12864; Q15336; Q2M2E0
Background:
Cadherin-17, also known as Liver-intestine cadherin and Intestinal peptide-associated transporter HPT-1, is a calcium-dependent cell adhesion protein. It plays a crucial role in the morphological organization of liver and intestine by preferentially interacting with itself in a homophilic manner, thus contributing to the sorting of heterogeneous cell types. Additionally, it is involved in intestinal peptide transport.
Therapeutic significance:
Understanding the role of Cadherin-17 could open doors to potential therapeutic strategies.